“the Takeda deal lets the company scale beyond its own pipeline and become a top global player in AI drug discovery”
“points to Insilico's thirty one developmental candidates as proof its platform delivers real drugs, not just software”
“roughly sixty million upfront with the remaining six hundred million tied to milestones and royalties”
“In many ways, Lilly is better than us in some areas of AI”
“Insilico has developed at least 28 drugs using generative AI tools, with nearly half already at a clinical stage, Alex Zhavoronkov, founder and CEO of Insilico, told CNBC.”
“Lilly is better in AI than Insilico, and no other company is better in AI than us … except for these guys.”
“Mounjaro makes me so happy every day. I want to develop the next one.”
“Alex Zhavoronkov, Founder and CEO of generative-AI drug discovery firm Insilico Medicine, discusses the company's plans after it raised $293 million in its initial public offering in Hong…”
“He talks about using artificial intelligence in early-stage drug discovery, longevity therapeutics, and how Insilico's AI model can simulate different life stages.”